IFNA1 and chronic hepatitis C virus infection: Among the side effects of IFN therapy, oral lesions might be easy to be overlooked and, among the side effects in a Japanese Phase III trial of Peg-IFN/RBV, oral mucosal disease and dental problems have been documented in patients with chronic hepatitis C.